With applications ranging from organoid to rodent to large-animal research, scientific sessions at SAMS 2027 will spotlight pioneering advancements in all applications of preclinical MRI: neurology, oncology, cardiology, tumor imaging, cell tracking and more. Discussions will also include advancements in hardware design, sequence and protocol development, image postprocessing, contrast agents and X-nuclei labeling, MR spectroscopy and CEST imaging, multimodal imaging applications, machine learning and AI-assisted analysis workflows. Finally, this year’s edition of SAMS will be rounded up with a panel discussion on making ends meet when running an imaging facility.
Conference topics
Neuroimaging, fMRI & networks
Molecular & metabolic MRI
Cardiac MRI
Musculoskeletal MRI
MRI in oncology
MR spectroscopy & CEST imaging
Cell labeling & tracking, theranostics
X-nuclei imaging
Contrast agents and mechanisms
Multimodal and translational imaging
MRI method development
MRI hardware design
Translational MRI imaging
MRI facility design and operation
Any other MRI related research
Molecular & metabolic MRI
Cardiac MRI
Musculoskeletal MRI
MRI in oncology
MR spectroscopy & CEST imaging
Cell labeling & tracking, theranostics
X-nuclei imaging
Contrast agents and mechanisms
Multimodal and translational imaging
MRI method development
MRI hardware design
Translational MRI imaging
MRI facility design and operation
Any other MRI related research
This year's edition of Small Animal MRI Symposium will host a true who-is-who in the world of pre-clinical and translational MRI imaging. Find out more about our invited and keynote speakers below.
Prof. Mathias Hoehn
Max Planck Institute for Metabolism Research / University of Cologne, Germany
Max Planck Institute for Metabolism Research / University of Cologne, Germany
Prof. Mathias Hoehn is a prominent biophysicist and neuroscientist who served as the long-time Head of the In-vivo NMR Research Group at the Max Planck Institute for Metabolism Research in Cologne, Germany. After earning his PhD from the University of Regensburg, he dedicated his career to advancing functional neuroimaging and in-vivo nuclear magnetic resonance technologies. His pioneering research focused heavily on molecular MR imaging, specifically cell labeling and tracking within the central nervous system. Beyond his work at Max Planck Institute, he was appointed Professor at the University of Cologne in 1996 and served as a Visiting Professor at Leiden University Medical Center. A renowned leader in the field, he also served as the President of the European Society for Molecular Imaging.
Philipp Boehm-Sturm, Charité – Universitätsmedizin Berlin, Germany
Cornelius Faber, University of Münster, Germany
Ulrich Flögel, Heinrich Heine University Düsseldorf, Germany
Uwe Himmelreich, KU Leuven, Belgium
Hervé Boutin, INSERM U1253 iBrain / University of Tours, France
Laura-Adela Harsan, University of Strasbourg, University Hospital Strasbourg, France
Noam Shemesh, Weizmann Institute of Science, Israel
Dario Longo, CNR Institute of Biostructures and Bioimaging, Turin, Italy
Daniele Bertoglio, University of Antwerp, Belgium
Marlène Wiart, Université Lyon 1, France
Fabian Kießling, RWTH Aachen University, Germany
Milan Radoš, University of Zagreb School of Medicine, Croatia
Aleksandra Dugandžić, University of Zagreb School of Medicine, Croatia
Cornelius Faber, University of Münster, Germany
Ulrich Flögel, Heinrich Heine University Düsseldorf, Germany
Uwe Himmelreich, KU Leuven, Belgium
Hervé Boutin, INSERM U1253 iBrain / University of Tours, France
Laura-Adela Harsan, University of Strasbourg, University Hospital Strasbourg, France
Noam Shemesh, Weizmann Institute of Science, Israel
Dario Longo, CNR Institute of Biostructures and Bioimaging, Turin, Italy
Daniele Bertoglio, University of Antwerp, Belgium
Marlène Wiart, Université Lyon 1, France
Fabian Kießling, RWTH Aachen University, Germany
Milan Radoš, University of Zagreb School of Medicine, Croatia
Aleksandra Dugandžić, University of Zagreb School of Medicine, Croatia